Fabrication and functional validation of a hybrid biomimetic nanovaccine (HBNV) against KitK641E-mutant melanoma

Fabrication and functional validation of a hybrid biomimetic nanovaccine (HBNV) against KitK641E-mutant melanoma

Cancer nanovaccines hold the promise for personalization, precision, and pliability by integrating all the elements essential for effective immune stimulation. An effective immune response requires communication and interplay between antigen-presenting cells (APCs), tumor cells, and immune cells to...

Full description

Saved in:
Bibliographic Details
Main Authors: Kishwor Poudel, Zhenyu Ji, Ching-Ni Njauw, Anpuchchelvi Rajadurai, Brijesh Bhayana, Ryan J. Sullivan, Jong Oh Kim, Hensin Tsao
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2025-04-01
Series:Bioactive Materials
Subjects:
Cancer vaccines
Immunotherapy
KIT-Mutant melanoma
Nanovaccines
Hybrid
Online Access:http://www.sciencedirect.com/science/article/pii/S2452199X24005607
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2452199X24005607

Similar Items